Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
nature of this project, please contact Prof. Tony McNally (T.McNally@warwick.ac.uk ) directly for further information. Essential and Desirable Criteria: 1 or 2.1 degree in chemistry, chemical engineering
-
& Integrative Neuroscience (Lab CLINT) aims to advance fundamental knowledge of human brain function and to use this knowledge to help people with psychiatric and neurological disorders. Our research integrates
-
and materials engineering. For more information about the APE group please use the following link: www.rug.nl/research/ape. The project cooperates with the Bernoulli Institute of Mathematics
-
Closing Date: 15th September 2025 [23:59 GMT] Supervisor: Prof M. Sumetsky Prospective Start Date: 1 January 2026 Applications are invited for a Postgraduate studentship, supported by Aston
-
/ The underlying project is under supervision of Prof. Dr. Peter Zaspel and Prof. Dr. Michael Günther. The team of Prof. Peter Zaspel is located at Bergische Universität Wuppertal. The international team focuses
-
: law regulation social sciences bioethics health services health/public policy other relevant disciplines. Some grounding in law and/or regulation is desirable. How to apply You must submit an expression
-
academic area such as applied mathematics, computer science, physics, biomedical or electrical engineering or similar disciplines. Good programming expertise (Matlab, C++, Python or equivalent) and
-
and use innovative approaches to identify and characterise the chemical and physical interactions between cells that result in inhibition of detrimental fungi. This bioprospecting project will utilise
-
collaboration with the industrial partner SCA Supervisors Prof Sebastian Bader (Mid Sweden University) D r Domenico Balsamo (Newcastle University) Eligibility Criteria Home applicants (UK) are welcome to apply
-
Building. You will join the Research Unit for Molecular Pharmacology, led by Prof. Timo Müller. The group's research is dedicated to the development of innovative pharmacotherapies aimed at safely and